Introduction of a prognostic biomarker to strengthen risk stratification of acutely admitted patients: rationale and design of the TRIAGE III cluster randomized interventional trial
Crossref DOI link: https://doi.org/10.1186/s13049-016-0290-8
Published Online: 2016-08-05
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sandø, Andreas
Schultz, Martin
Eugen-Olsen, Jesper
Rasmussen, Lars Simon
Køber, Lars
Kjøller, Erik
Jensen, Birgitte Nybo
Ravn, Lisbet
Lange, Theis
Iversen, Kasper
Funding for this research was provided by:
Virogates A/S Birkeroed, DK